CR Medicon

With adverse drug event monitoring developing rapidly, this China annual report on ADR & ADE monitoring is more important than ever.

See the full English version here;
http://ow.ly/l1n550xPmUw

China Annual ADR & ADE Monitoring Report (2018) - CR Medicon In this CR Medicon publication, we review NMPA's China 2018 ADR & ADE monitoring report in English, as an integral part of pharmacovigilance.

CR MEDICON would like to wish you a very happy and prosperous New Year!

CR Medicon is now hiring an Associate Director, Statistics. Come join our team!


https://en.crmedicon.com/job/associate-director-statistics-2/

CR Medicon has the industry's leading drug metabolism scientists and experienced operational management.

Our biological sample analysis team delivers research results, monitors regulatory trends and provides feedback and solutions to client issues.

Bioanalytical Lab Testing - CR Medicon CR Medicon heavily invested and established in China a state-of-the-art biological sample analysis laboratory with advanced equipment and management standards. Our team has the industry's leading drug metabolism scientists and experienced operational management.  Combined with our global str...